Cargando…

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease

Background: Abnormal accumulation of lipids is found in dopamine neurons and resident microglia in the substantia nigra of patients with Parkinson’s disease (PD). The accumulation of lipids is an important risk factor for PD. Previous studies have mainly focussed on lipid metabolism in peripheral bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jiewen, Wei, Lijian, Su, Yilin, Tang, Yuting, Peng, Guoyou, Wu, Yimin, He, Yan, Liu, Hanqun, Guo, Wenyuan, Wu, Zhuohu, Xu, Pingyi, Mo, Mingshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452343/ https://www.ncbi.nlm.nih.gov/pubmed/37626522 http://dx.doi.org/10.3390/brainsci13081166

Ejemplares similares

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)

Association of LAG3 genetic variation with an increased risk of PD in Chinese female population
por: Guo, Wenyuan, et al.
Publicado: (2019)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease
por: Chen, Xiang, et al.
Publicado: (2023)

A case of congenital afibrinogenemia with multiple thrombotic and hemorrhagic disorders
por: Wei, Lijian, et al.
Publicado: (2022)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
por: Lu, Lin, et al.
Publicado: (2022)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease: A protocol for systematic review and meta-analysis
por: Wang, HongZhou, et al.
Publicado: (2020)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Profiling of Cerebrospinal Fluid Lipids and Their Relationship with Plasma Lipids in Healthy Humans
por: Saito, Kosuke, et al.
Publicado: (2021)

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
por: Do, Khanh V., et al.
Publicado: (2022)

Plasma Lipolysis and Changes in Plasma and Cerebrospinal Fluid Signaling Lipids Reveal Abnormal Lipid Metabolism in Chronic Migraine
por: Castor, Katherine, et al.
Publicado: (2021)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
por: Lobanova, Evgeniia, et al.
Publicado: (2021)

Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease
por: Wei, Lei, et al.
Publicado: (2019)

The biomarkers of immune dysregulation and inflammation response in Parkinson disease
por: Chen, Li, et al.
Publicado: (2016)

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)

T-Cell Subsets in the Cerebrospinal Fluid and Peripheral Blood of Patients with Parkinson's Disease
por: Pavón, N., et al.
Publicado: (1992)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: Hatcher-Martin, J. M., et al.
Publicado: (2021)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Corrigendum to: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Publicado: (2021)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study
por: Li, Yongang, et al.
Publicado: (2023)

Cerebrospinal Fluid
por: Bailey, Cleta Sue, et al.
Publicado: (1997)

Cerebrospinal Fluid
por: Vernau, William, et al.
Publicado: (2008)

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
por: Huang, Shuxuan, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson’s disease in Indian population
por: Sanyal, Jaya, et al.
Publicado: (2016)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a2bsv1pkiatpn74hc4rtu5uc95